Although a previous study demonstrated that 80% of intestinal-type GC specimens expressed TGF-β1 compared to only 43% of diffuse-type [10], we found no difference in the expression of TGF-β1 in relation to Hp infection, Lauren’s classification, or lymph node involvement. The gene discussed is TGFB1; the disease is gastric cancer.